Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation

Clinical Transplantation

Volumn 20, Issue 3, 2006, Pages 272-283

  Langrehr, Jan M ^a   Klupp, Jochen ^a   Glanemann, Matthias ^a   Junge, Guido ^a   Pfitzmann, Robert ^a   Bahra, Marcus ^a   Radtke, Cornelia ^b   Neumann, Ulf ^a   Neuhaus, Ruth ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DRK KLINIKEN BERLIN WESTEND   (Germany)

Author keywords

Cyclosporine; Liver transplantation; Mycophenolate mofetil; Tacrolimus

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; CYCLOSPORIN A; HEPATITIS B ANTIBODY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; METRONIDAZOLE; MINERAL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; POLYMYXIN B; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; TOBRAMYCIN; URSODEOXYCHOLIC ACID; VITAMIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; BLOOD TOXICITY; BODY WEIGHT DISORDER; BONE MARROW TOXICITY; CHOLANGITIS; CLINICAL PROTOCOL; CLINICAL STUDY; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRAFT SURVIVAL; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER DISEASE; LIVER DYSFUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OBSERVATIONAL STUDY; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE CARE; REMISSION INDUCTION; TACROLIMUS; TIME FACTORS;

EID: 33745072778     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00485.x     Document Type: Article

References (34)

1. Sollinger HW for the US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995: 60: 225.
2. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995: 345: 1321.
3. Tricontinental Mycophenolate Mofetil Renal Transplant Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996: 61: 1029.
4. McDiarmid SV. Mycophenolate mofetil in liver transplantation. Clin Transplant 1996: 10: 140.
5. Hood KA, Zarembski DG. Mycophenolate mofetil: A unique immunosuppressive agent. Am J Health-Syst Pharm 1997: 54: 285.
6. Klupp J, Bechstein WO, P latz KP et al. Mycophenolate mofetil added to immunosuppression after liver transplantation - first results. Transplant Int 1997: 10: 223.
7. Platz KP, Mueller AR, Neuhaus R, Keck H, Lobeck H, Neuhaus P. FK506 and mycophenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation. Transplant Proc 1997: 29: 2872.
8. Paterson DL, Singh N, Panebianco A et al. Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. Transplantation 1998: 66: 593.
9. Eckhoff DE, Mc Guire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 1998: 65: 180.
10. Jain A, Kashyap R, Dodson F et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: A single center report. Transplantation 2001: 27: 1091.
11. Fisher RA, Stone JJ, Wolfe LG et al. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation. Clin Transplant 2004: 18: 463.
12. Klintmalm GB, Ascher NL, Busuttil RW et al. RS-61443 for treatment-resistant human liver rejection. Transplant Proc 1993: 25: 697.
13. Pfitzmann R, Klupp J, Langrehr JM et al. Mycophenolate mofetil for immunosuppression after liver transplantation: A follow-up study of 191 patients. Transplantation 2003: 76: 130.
14. Cantarovich M, Tzimas GN, Barkun J, Deschenes M, Alpert E, Tchervenkov J. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction. Transplantation 2003: 76: 98-102.
15. Raimondo ML, Dagher L, Papatheodoridis GV et al. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation 2003: 75: 186.
16. Zucker K, Rosen A, Tsaroucha A et al. Unexpected augmentation of mycophenolate acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transplant Immunol 1997: 5: 225.
17. Huber GI, Eismann R, Sziegoleit W. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolate acid monitoring in renal transplant recipients. Drug Monit 1999: 21: 536.
18. Jain A, Kashyap R, Demetris J, Eghstesad B, Pokharna R, Fung JJ. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transplant 2002: 8: 40.
19. Neuhaus P, Langrehr JM, Williams R, Calne RY, Pichlmayr R, McMaster P. Tacrolimus-based immunosuppression after liver transplantation: A randomized study comparing dual versus triple low-dose oral regimes. Transplant Int 1997: 10: 253.
20. Langrehr JM, Glanemann M, Guckelberger O et al. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation. Clin Transplant 1998: 12: 303.
21. Neuhaus P, Blumhardt G, Bechstein WO, S teffen R, P latz KP, K eck H. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 1994: 219: 426.
22. Glanemann M, Langrehr JM, Kaisers U et al. Postoperative tracheal extubation after orthotopic liver transplantation. Acta Anaesthesiol Scand 2001: 45: 333.
23. Langrehr JM, Nüssler NC, N eumann U et al. A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation. Transplantation 1997: 63: 1772.
24. Steinmuller T, Seehofer D, Rayes N et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002: 35: 1528.
25. Shaw LM, Kaplan B, Brayman KL. Prospective investigations of concentration - clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring. Clin Chem 1998: 44: 381.
26. Neuhaus P, Bechstein WO, Blumhardt G et al. Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 1993: 55: 1320.
27. Neuhaus P, Blumhardt G, Bechstein WO et al. Comparison of tacrolimus- and cyclosporine A-based immunosuppression in primary orthotopic liver transplantation. Transplantation 1995: 59: 31.
28. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft transplants. Transplantation 1997: 63: 39.
29. Gavlik A, Demirbas A, Tsaroucha A et al. Mycophenolate mofetil rescue therapy in liver transplant recipients: An extended follow-up. Transplant Proc 1997: 29: 2971.
30. Stegall MD, Wachs ME, Everson G et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate. A prospective trial of cyclosporine and tacrolimus. Transplantation 1997: 64: 1755.
31. Jain A, Hamad I, Rakela J et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplant recipients. An interim report. Transplantation 1998: 66: 1395.
32. Cai TH, Esterl RM Jr, Nichols L, Cigarroa F, Speeg KV, Halff GA. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. Transplant Proc 1998: 30: 1413.
33. Smak Gregoor PJ, van Gelder T, Hesse CJ, van der Mast BJ, van Besouw NM, Weimar W. Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporine: A cross-sectional study. Nephrol Dial Transplant 1999: 14: 706.
34. Langrehr JM, Neumann UP, Lang M et al. First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. Transplant Proc 2002: 34: 1565.